A Rollover Study of NBM-BMX in Combination With Temozolomide in Patients With Newly Diagnosed Glioblastoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Temozolomide
Related studies linked through entity extraction aliases.
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Integrating Biology for Safe Intensification of Glioblastoma Hypofractionated Treatment on the MR-Linac
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Evaluation of UCPVax Vaccine +/- Pembrolizumab Combined With Standard Treatment as Adjuvant Therapy in Patients With Unmethylated MGMT Glioblastoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Clinical Trial Testing the Safety of the Investigational Drug Pumitamig (BNT327) and How Well it Works in Patients With Recurrent Glioblastoma
- Status
- RECRUITING
- Phase
- PHASE2
A Study of 177Lu-PSMA-617 in People With Gliomas
- Status
- RECRUITING
- Phase
- PHASE1
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
- Status
- RECRUITING
- Phase
- PHASE3
Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes
- Status
- RECRUITING
- Phase
- PHASE1
An Umbrella Study of Recurrent, Extensive Stage Small Cell Lung Cancer Based on Molecular Typing
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
IGNITE: Study of Tirabrutinib vs Rituximab/Temozolomide for Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL)
- Status
- RECRUITING
- Phase
- PHASE3
A Phase II Study With a Safety Run-In of the Addition of N-803 to a Chemoimmunotherapy Backbone for the Treatment of Patients With Relapsed or Refractory Neuroblastoma
- Status
- RECRUITING
- Phase
- PHASE2
Feasibility Study of Prolonged Administration of Naxitamab, Irinotecan, and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma
- Status
- RECRUITING
- Phase
- PHASE1
Sequential Treatments or Combinations Including Dasatinib, Quercetin, Fisetin and/or Temozolomide for the Treatment of Previously Treated Glioma With Residual Disease
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
Phase I Trial of rhIL-15 Plus Dinutuximab Plus Irinotecan/Temozolomide for Children and Young Adults With Relapsed/Refractory Neuroblastoma
- Status
- RECRUITING
- Phase
- PHASE1
Ruxolitinib With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma
- Status
- RECRUITING
- Phase
- PHASE2
Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma
- Status
- RECRUITING
- Phase
- PHASE1